Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells

Chi Cheng Lu, Pei Yi Chu, Shih Min Hsia, Chi Hao Wu, Yu Tang Tung, Gow Chin Yen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The progression of colorectal cancer has been reported to have a positive correlation with the combination of hyperglycemia and hyperinsulinemia in diabetic patients, leading to a lower survival rate. However, how insulin acts on colorectal cancer remains not well understood. The purpose of this study was to explore the effect of insulin on colon cancer cell proliferation and its underlying molecular signaling as well as the impact of insulin-induced in vitro metastasis. Our results showed that insulin markedly promoted cell proliferation, migration and anchorage-independent growth in human colon cancer HCT-116 cells. Insulin-regulated insulin receptors (IRs) stimulate insulin receptor substrate 1 (IRS-1) and interact with the downstream signals, causing a rise in HCT-116 cell proliferation. Moreover, insulin significantly induced the migration ability of HCT-116 cells. The metastatic ability of matrix metalloproteinase-2 (MMP-2) mRNA and activity was activated by insulin. Overall, insulin-triggered cell proliferation and metastatic effects on colorectal cancer cells are mediated by IRS-1 and downstream molecules and by increasing phosphoinositide 3-kinase (PI3K)/Akt and mitogenactivated protein kinase (MAPK) signaling. Therefore, insulin induction might have the potential to induce colorectal cancer progression in diabetes patients.

Original languageEnglish
Pages (from-to)736-744
Number of pages9
JournalInternational Journal of Oncology
Volume50
Issue number2
DOIs
Publication statusPublished - Feb 1 2017

Fingerprint

Colorectal Neoplasms
Cell Proliferation
Insulin
Neoplasm Metastasis
HCT116 Cells
Insulin Receptor Substrate Proteins
Colonic Neoplasms
1-Phosphatidylinositol 4-Kinase
Matrix Metalloproteinase 2
Insulin Receptor
Hyperinsulinism
Hyperglycemia
Protein Kinases
Cell Movement
Survival Rate
Messenger RNA
Growth

Keywords

  • Cell Migration
  • Cell proliferation
  • Colon cancer
  • Diabetes
  • Insulin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells. / Lu, Chi Cheng; Chu, Pei Yi; Hsia, Shih Min; Wu, Chi Hao; Tung, Yu Tang; Yen, Gow Chin.

In: International Journal of Oncology, Vol. 50, No. 2, 01.02.2017, p. 736-744.

Research output: Contribution to journalArticle

@article{6b2da9607c1c4d3099798664ff7578f8,
title = "Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells",
abstract = "The progression of colorectal cancer has been reported to have a positive correlation with the combination of hyperglycemia and hyperinsulinemia in diabetic patients, leading to a lower survival rate. However, how insulin acts on colorectal cancer remains not well understood. The purpose of this study was to explore the effect of insulin on colon cancer cell proliferation and its underlying molecular signaling as well as the impact of insulin-induced in vitro metastasis. Our results showed that insulin markedly promoted cell proliferation, migration and anchorage-independent growth in human colon cancer HCT-116 cells. Insulin-regulated insulin receptors (IRs) stimulate insulin receptor substrate 1 (IRS-1) and interact with the downstream signals, causing a rise in HCT-116 cell proliferation. Moreover, insulin significantly induced the migration ability of HCT-116 cells. The metastatic ability of matrix metalloproteinase-2 (MMP-2) mRNA and activity was activated by insulin. Overall, insulin-triggered cell proliferation and metastatic effects on colorectal cancer cells are mediated by IRS-1 and downstream molecules and by increasing phosphoinositide 3-kinase (PI3K)/Akt and mitogenactivated protein kinase (MAPK) signaling. Therefore, insulin induction might have the potential to induce colorectal cancer progression in diabetes patients.",
keywords = "Cell Migration, Cell proliferation, Colon cancer, Diabetes, Insulin",
author = "Lu, {Chi Cheng} and Chu, {Pei Yi} and Hsia, {Shih Min} and Wu, {Chi Hao} and Tung, {Yu Tang} and Yen, {Gow Chin}",
year = "2017",
month = "2",
day = "1",
doi = "10.3892/ijo.2017.3844",
language = "English",
volume = "50",
pages = "736--744",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Insulin induction instigates cell proliferation and metastasis in human colorectal cancer cells

AU - Lu, Chi Cheng

AU - Chu, Pei Yi

AU - Hsia, Shih Min

AU - Wu, Chi Hao

AU - Tung, Yu Tang

AU - Yen, Gow Chin

PY - 2017/2/1

Y1 - 2017/2/1

N2 - The progression of colorectal cancer has been reported to have a positive correlation with the combination of hyperglycemia and hyperinsulinemia in diabetic patients, leading to a lower survival rate. However, how insulin acts on colorectal cancer remains not well understood. The purpose of this study was to explore the effect of insulin on colon cancer cell proliferation and its underlying molecular signaling as well as the impact of insulin-induced in vitro metastasis. Our results showed that insulin markedly promoted cell proliferation, migration and anchorage-independent growth in human colon cancer HCT-116 cells. Insulin-regulated insulin receptors (IRs) stimulate insulin receptor substrate 1 (IRS-1) and interact with the downstream signals, causing a rise in HCT-116 cell proliferation. Moreover, insulin significantly induced the migration ability of HCT-116 cells. The metastatic ability of matrix metalloproteinase-2 (MMP-2) mRNA and activity was activated by insulin. Overall, insulin-triggered cell proliferation and metastatic effects on colorectal cancer cells are mediated by IRS-1 and downstream molecules and by increasing phosphoinositide 3-kinase (PI3K)/Akt and mitogenactivated protein kinase (MAPK) signaling. Therefore, insulin induction might have the potential to induce colorectal cancer progression in diabetes patients.

AB - The progression of colorectal cancer has been reported to have a positive correlation with the combination of hyperglycemia and hyperinsulinemia in diabetic patients, leading to a lower survival rate. However, how insulin acts on colorectal cancer remains not well understood. The purpose of this study was to explore the effect of insulin on colon cancer cell proliferation and its underlying molecular signaling as well as the impact of insulin-induced in vitro metastasis. Our results showed that insulin markedly promoted cell proliferation, migration and anchorage-independent growth in human colon cancer HCT-116 cells. Insulin-regulated insulin receptors (IRs) stimulate insulin receptor substrate 1 (IRS-1) and interact with the downstream signals, causing a rise in HCT-116 cell proliferation. Moreover, insulin significantly induced the migration ability of HCT-116 cells. The metastatic ability of matrix metalloproteinase-2 (MMP-2) mRNA and activity was activated by insulin. Overall, insulin-triggered cell proliferation and metastatic effects on colorectal cancer cells are mediated by IRS-1 and downstream molecules and by increasing phosphoinositide 3-kinase (PI3K)/Akt and mitogenactivated protein kinase (MAPK) signaling. Therefore, insulin induction might have the potential to induce colorectal cancer progression in diabetes patients.

KW - Cell Migration

KW - Cell proliferation

KW - Colon cancer

KW - Diabetes

KW - Insulin

UR - http://www.scopus.com/inward/record.url?scp=85013073478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013073478&partnerID=8YFLogxK

U2 - 10.3892/ijo.2017.3844

DO - 10.3892/ijo.2017.3844

M3 - Article

C2 - 28101572

AN - SCOPUS:85013073478

VL - 50

SP - 736

EP - 744

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -